Investor Overview

Investor Presentation
Financial News
Nov 5, 2019

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today reported financial results for the three and six months ended...

Oct 17, 2019

/NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES./ TORONTO and HOUSTON, Oct. 17, 2019 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields